Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Sormani

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.
Neurology|May 5, 1998
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosisG L Mancardi, F Sardanelli, R C Parodi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2013
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo studyG Comi, M A Battaglia, A Bertolotto, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2012
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paperR Saccardi, M S Freedman, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|July 11, 2001
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MSG L Mancardi, R Saccardi, M Filippi, et al.
European Journal of Neurology|August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered gloveL Carmisciano, A Signori, M Pardini, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.
Neurology|May 5, 1998
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosisG L Mancardi, F Sardanelli, R C Parodi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2013
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo studyG Comi, M A Battaglia, A Bertolotto, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Brain : a Journal of Neurology|August 22, 2006
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsM Rovaris, E Judica, A Gallo, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2012
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paperR Saccardi, M S Freedman, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|July 11, 2001
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MSG L Mancardi, R Saccardi, M Filippi, et al.
European Journal of Neurology|August 18, 2020
Assessing upper limb function in multiple sclerosis using an engineered gloveL Carmisciano, A Signori, M Pardini, et al.
Pageof 11